Upcoming Webinars
Webinar Archives
Epitranscriptomics and Disease: The Role of RNA Modification in the Life Cycle of the Cell
JUNE 30, 2021
Program | Sponsored by:
Zobio
Prof. Sebastian Leidel, Professor for RNA Biochemistry, Department of Chemistry, Biochemistry and Pharmaceutical Sciences (DCBP)
University of Bern, Switzerland
Prof. Samie R. Jaffrey, M.D., Ph.D., Greenberg-Starr Professor of Pharmacology, The Department of Pharmacology
Weill Cornell Medicine, NYC
Dr. Gregg Siegal, CEO
ZoBio
Practical Strategies for Overcoming Challenges in the Development of AAV vectors for Gene Therapy
FEBRUARY 24, 2021
Program | Sponsored by:
NanoTemper
Santoshkumar L. Khatwani, PhD
Santoshkumar L. Khatwani, PhD, Associate Director, Analytical Development
Sangamo Therapeutics
Xiaoying Jin, PhD
Greenberg-Starr Professor of Pharmacology
Senior Principal Scientist
Sanofi
Understanding the Nuances of Targeted Protein Degradation
DECEMBER 10, 2020
Program | Sponsored by: NanoTemper
Stewart Fisher, PhD
Chief Scientific Officer
C4 Therapeutics
Alessio Ciulli, PhD
Professor of Chemical and Structural Biology, School of Life Sciences
University of Dundee
Drug Discovery Powered by HUB Organoids
OCTOBER 26, 2020
Program | Sponsored by: HUB
Robert Vries, PhD
CEO
Hubrecht Organoid Technology (HUB)
The Role of 3D in the Fight Against SARS-CoV-2: Using Organoids for COVID-19 Disease Models and Organoid Best Practices
OCTOBER 21, 2020
Program | Sponsored by: Corning
Shuibing Chen, PhD
Kilts Family Associate Professor, Director of Diabetes Program, Department of Surgery
Weill Cornell Medicine
Austin Mogen, PhD
Senior Field Application Scientist
Corning Life Sciences
Researching and Targeting Tumor Microenvironment: New Frontline in Immuno-Oncology Research
SEPTEMBER 30, 2020
Program | Sponsored by: AIM Biotech MilliporeSigma
Russell W. Jenkins, MD, PhD
Assistant Professor
Dept. of Medicine, Center for Cancer Research, Massachusetts General Hospital
Viviana Cremasco, PhD
Investigator III, Exploratory Immuno-Oncology
Novartis
Pushpa Jayaraman, PhD
Senior Investigator I, Exploratory Immuno-Oncology
Novartis Institutes for Biomedical Research
Chairperson: Kuan Chee Mun
CEO
AIM Biotech
Formulation and Stability Screening of Biotherapeutics
SEPTEMBER 23, 2020
Program | Sponsored by: Nanotemper
Charles Heffern
Product Manager, NanoTemper
Jie Wen
Senior Scientist, Higher Order Structure, Biological Relevance and Characterization, Attribute Sciences Amgen, Thousand Oaks
Novel Drug Modalities & Integrated Platforms to Transform R&D Productivity
JULY 16, 2020
Program | Sponsored by: Research Solutions / Reprints Desk
James (Jay) Bradner, MD, President
Novartis Institutes for BioMedical Research (NIBR)
Mitja-Alexander Linss
Director of Marketing at Research Solutions
Reprints Desk
Tomi K Sawyer, PhD
President & Chief Drug Hunter, Maestro Therapeutics
Individual Consultant
Anabella Villalobos, PhD
Senior Vice-President, Biotherapeutics and Medicinal Sciences
Biogen